September 1 (Thu)

[PL01] Plenary Session 1: State of the Art in Cell Therapy

Date & Time	September 1 (Thu), 09:30-10:50	Room A
Chair	Hong Ghi Lee (Konkuk University College of Medicine, Korea)
Presentations	T-cell Therapies for Blood Cancers Catherine Bollard (George Washington University, USA) Multi-targeted CAR-T Therapy – Overcoming CD19 Antigen Loss David B. Miklos (Stanford University, USA)

[PL02] Plenary Session 2: How to Treat Steroid-Refractory Graft vs. Host Disease

Date & Time	September 1 (Thu), 11:00-12:20	Room A
Chair	Hoon Kook (Chonnam National University Medical School, Korea)
Presentations	Treatment for Steroid-Refractory Acute GVHD Paul J. Martin (Fred Hutchinson Cancer Center, USA) Treatment for Steroid-Refractory Chronic GVHD Takanori Teshima (Hokkaido University Hospital, Japan)

[LS01] Luncheon Symposium 1: Kyowa Kirin Korea

Date & Time	September 1 (Thu), 12:40-13:20	Room A
Chair	Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation	Impact of pegfilgrastim approval on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma Tatsu Shimoyama (Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Japan)

[LS02] Luncheon Symposium 2: Janssen Korea

Date & Time	September 1 (Thu), 12:40-13:20	Room B
Chair	Ho-Jin Shin (Pusan National University School of Medicine, Korea)
Presentation	Treatment of Newly Diagnosed Transplant Eligible Myeloma : What is the Optimal Induction? Mario Boccadoro (University of Turin, Italy)

[LS03] Luncheon Symposium 3: Novartis Korea

Date & Time	September 1 (Thu), 12:40-13:20	Room C
Chair	Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Presentation	How to Treat Steroid Refractory GvHD Optimally with Ruxolitinib Robert Zeiser (University Medical Center Freiburg, Germay)

[LS04] Luncheon Symposium 4: Astellas Pharma Korea

Date & Time	September 1 (Thu), 12:40-13:20	Room D
Chair	Hee-Je Kim (The Catholic University of Korea, Korea)
Presentation	Optimizing the management of FLT3 mt R/R AML in older and frail patient Eunice Wang (Roswell Park Comprehensive Cancer Center, USA)

[JS01] Joint Symposium 1: JSTCT-KSBMT: Unmet Needs of Alternative Donor Transplantation in SAA

Date & Time	September 1 (Thu), 14:40-16:20	Room A
Chair	Hee-Je Kim (The Catholic University of Korea, Korea) Takanori Teshima (Hokkaido University Hospital, Japan)
Presentations	TBI-Containing Conditioning Regimens without ATG in Adults with Aplastic Anemia Undergoing CBT Nobuhiro Hiramoto (Kobe City Medical Center General Hospital, Japan) Alternative Donor HSCT for Pediatirc SAA in Korea Jae Wook Lee (The Catholic University of Korea, Korea) Investigation of Telomere Length Shortening in Pediatric Aplastic Anemia and Congenital Bone Marrow Failure Atsushi Narita (Nagoya University, Japan) Comparison of HSCT and TPO-RAs with IST in SAA Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)

[SS01] Scientific Session 1: Strategies to Prevent Leukemia Relapse after HSCT

Date & Time	September 1 (Thu), 14:40-16:10	Room B
Chair	Jong Ho Won (Soonchunhyang University College of Medicine, Korea) Byung Sik Cho (The Catholic University of Korea, Korea)
Presentations	Maintenance Therapy in AML to Prevent Relapse after Allogeneic HSCT Uwe Platzbecker (Leipzig University Hospital, Germany) Management of Acute Leukemias Relapsing after the First Allogeneic HCT: A Second Allogeneic HCT or DLI? Mohamed A. Kharfan-Dabaja (Mayo Clinic, USA) Relapse Prevention after Allogeneic HSCT in Adult ALL Nicola Gökbuget (Goethe University, Germany)

[ES01] Education Session 1: What Should We Know to Reduce Transplant-Related Mortality

Date & Time	September 1 (Thu), 14:40-16:10	Room C
Chair	Hyeon Seok Eom (National Cancer Center, Korea) Joon Seong Park (Ajou University School of Medicine, Korea)
Presentations	Diagnosis and Management of Vascular Endothelial Syndrome after HSCT Thomas Luft (University of Heidelberg, Germany) Optimal Administration of Antifungal Agents during Transplantation Malgorzata Mikulska (University of Genoa, Italy) Updates of Prophylaxis and Treatment with Viral Infections in Transplant Setting Young Kyung Yoon (Korea University College of Medicine, Korea)

[NS01] Nursing Session 1: Special Nursing Field of Hemato-Oncology Nurses (Kor.)

Date & Time	September 1 (Thu), 14:40-16:10	Room D
Chair	Minjin Choi (Sungkyunkwan University School of Medicine, Korea)
Presentations	Palliative and Hospice Care for Children, Adolescents with Hematologic Malignancies Sun Hee Choi (The Catholic University of Korea, Korea) Nursing Strategies on CAR-T Cell Therapy Yujeong Kim (Samsung Medical Center, Korea)

[JS02] Joint Symposium 2: EBMT-KSBMT: Recent Advances in Haploidentical HSCT

Date & Time	September 1 (Thu), 16:30-18:10	Room A
Chair	Hee-Je Kim (The Catholic University of Korea, Korea) Anna Sureda (Catalan Institute of Oncology, Spain)
Presentations	New Strategies of Unmanipulated Haploidentical Cell Transplantation Annalisa Ruggeri (IRCCS San Raffaele Scientific Institute, Italy) Haplo-HCT vs. Other Sources Alberto Mussetti (Catalan Institute of Oncology, Spain) Graft Manipulation Strategies for Haploidentical Hematopoietic Cell Transplantation Ho Joon Im (University of Ulsan College of Medicine, Korea) Haploidentical Transplantation in Myeloid Maliagnancy: Is It a Just Alternative Option? Silvia Park (The Catholic University of Korea, Korea)

[SS02] Scientific Session 2: Donor Selection and Engraftment in HSCT

Date & Time	September 1 (Thu), 16:30-18:00	Room B
Chair	Kyoo-Hyung Lee (University of Ulsan College of Medicine, Korea) Chuhl Joo Lyu (Yonsei University College of Medicine, Korea)
Presentations	What to Consider in Donor Selection with Alternative Donors? Rupert Handgretinger (Eberhard Karls University Tuebingen, Germany) Primary Graft Failure in Pediatric Non-Malignant Disease: An Old but Critical Hurdle Troy Lund (University of Minnesota, USA) New Insights of Overcoming Poor Graft Function after Allogeneic HSCT in Hematologic Malignancies  Rajat Kumar (Princess Margaret Cancer Center, Canada)

[SS03] Scientific Session 3: Recent Advances in Transplant Immunology & Genomics

Date & Time	September 1 (Thu), 16:30-18:00	Room C
Chair	Je-Jung Lee (Chonnam National University Medical School, Korea) Myungshin Kim (The Catholic University of Korea, Korea)
Presentations	Suppressive Role of Bone Marrow-Derived IDO1 in Graft-Versus-Host Disease Eun Young Choi (Seoul National University College of Medicine, Korea) The Role of the Intestinal Microbiome in Cancer Immunotherapy Marcel van den Brink (Memorial Sloan Kettering Cancer Center, USA) Genomics in HSCT: Improving Transplant Outcomes Myungshin Kim (The Catholic University of Korea, Korea)

[DS01] Debate Session 1: Posttransplant Cyclophosphamide vs. Antithymocyte Globulin (Kor.)

* Simultaneous Korean-English interpreting will be provided.

Date & Time	September 1 (Thu), 16:20-18:00	Room D
Chair	Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Presentations	Debates in GVHD Prophylaxis - PTCY versus ATG: From the PTCY Perspective Ji Hyun Lee (Dong-A University College of Medicine, Korea) Debates in GVHD Prophylaxis- PTCy versus ATG: From the ATG Perspective Dong-Yeop Shin (Seoul National University College of Medicine, Korea)

[DS02] Debate Session 2: TBI vs. non-TBI for ALL Treatment (Kor.)

* Simultaneous Korean-English interpreting will be provided.

Date & Time	September 1 (Thu), 16:20-18:00	Room D
Chair	Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea)
Presentations	TBI Sung Han Kang (University of Ulsan College of Medicine, Korea) non-TBI Kyung Taek Hong (Seoul National University College of Medicine, Korea)

September 2 (Fri)

[EACS] East Asia Collaborative Session: Current Status of CAR-T Cell Therapy in East Asia

Date & Time	September 2 (Fri), 09:00-10:30	Room A
Chair	Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea) Bor-Sheng Ko (National Taiwan University Cancer Center, Taiwan)
Presentations	Current Status of CAR-T Cell Therapy in Taiwan Bor-Sheng Ko (National Taiwan University Cancer Center, Taiwan) Development of CAR-T in China Xiao jun Huang (Peking University Institute of Hematology, China) CAR T-Cell Therapy in Korea : Clinical Trials and Practice Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)

[JS03] Joint Symposium 3: ASTCT-KSBMT: Clonal Hematopoiesis and HSCT/Cellular Therapy

Date & Time	September 2 (Fri), 09:00-10:30	Room B
Chair	Hee-Je Kim (The Catholic University of Korea, Korea) Paul J. Martin (Fred Hutchinson Cancer Center, USA)
Presentations	Clonal Hematopoiesis in Donors for Allogeneic Hematopoietic Stem Cell Amy Dezern (Johns Hopkins University, USA) Pathobiology of Clonal Hematopoiesis and Hematologic Diseases Youngil Koh (Seoul National University College of Medicine, Korea) Clonal Hematopoiesis and Its Effects on Cellular Therapies (CAR T-Cell Therapy Outcomes) Kelly Bolton (Washington University School of Medicine in St. Louis, USA)

[SS04] Scientific Session 4: Hematopoietic Stem Cell Transplantation in Lymphoid Malignancy

Date & Time	September 2 (Fri), 09:00-10:40	Room C
Chair	Seok-Goo Cho (The Catholic University of Korea, Korea) Shin Ho-Jin (Pusan National University, Korea)
Presentations	Redefining the Role of Transplant for Patients with T-cell Lymphoma in the Immunotherapy Era Satoshi Yamasaki (National Hospital Organization Kyushu Medical Center, Japan) Updates of Consolidation and Maintenance Strategies in Primary CNS Lymphoma Tracy T Batchelor (Massachusetts General Hospital Cancer Center and Harvard Medical School, USA) The Future Directions of Maintenance with or without Consolidation Therapy in Myeloma Philip L. McCarthy (Roswell Park Cancer Institute, USA) Circulating miRNAs as Prognostic Biomarkers in Multiple Myeloma Patients Undergoing Transplant Sung-Soo Park (The Catholic University of Korea, Korea)

[ES02] Education Session 2: Practical Problems Related with CAR-T Cell Therapy

Date & Time	September 2 (Fri), 09:00-10:30	Room D
Chair	Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) Jin Seok Kim (Yonsei University College of Medicine, Korea)
Presentations	Recognizing and Managing CRS and ICANS: Emerging Roles of Alternative Agents Daniel W. Lee (University of Virginia, USA) Importance of Fludarabine Pharmacokinetics Kevin J Curran (Memorial Sloan Kettering Cancer Center, USA) Practical Considerations for Preparing CAR-T Cell Therapy Hee Young Ju (Sungkyunkwan University School of Medicine, Korea)

[SS05] Scientific Session 5: Database & Artificial Intelligence in Hematologic Malignancies

Date & Time	September 2 (Fri), 10:40-12:10	Room A
Chair	Seong Kyu Park (Soonchunhyang University College of Medicine, Korea) Hyery Kim (University of Ulsan College of Medicine, Korea)
Presentations	Optimal Donor Selection Algorithm Based on CIBMTR Data Bronwen Shaw (Medical College of Wisconsin, USA) Who to Transplant in CR1? Integrating Knowledge-Bank Approaches in Daily Practice Raphael Itzykson (Hopital Saint-Louis, France) St. Jude Cloud: A Genomic Data-Sharing Ecosystem for Advancing Research & Treatment in Pediatric Cancer & Blood Diseases Jinghui Zhang (St. Jude Children’s Research Hospital, USA)

[JS04] Joint Symposium 4: ISCT-KSBMT: Gene Editing and Gene Therapy

Date & Time	September 2 (Fri), 10:40-12:10	Room B
Chair	Je-Jung Lee (Chonnam National University Medical School, Korea) Byung Hyune Choi (ISCT Asia Regional VP, Inha University College of Medicine, Korea)
Presentations	Gene Editing for Treatment of Hematological Disorders Alok Srivastava (ISCT Member, Christian Medical College, India) Towards Next Generation T Cell Engineering for Cancer Immunotherapy Chan Hyuk Kim (KAIST, Korea) Enhanced Anti-Tumor Effects of Glioblastoma-Targeting CAR-T Cells by CRISPR-Cas9 Jung Min Lee (Handong University School of Life Science, Korea)

[ES03] Education Session 3: Survivorship after HSCT: Focusing on Rare Complications

Date & Time	September 2 (Fri), 10:40-12:10	Room D
Chair	Hyeon Jin Park (National Cancer Center, Korea) Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
Presentations	Cardiovascular Health after Hematopoietic Cell Transplantation Melissa Hudson (St. Jude Children's Research Hospital, USA) Bone Health in Hematologic Stem Cell Transplant Recipients David Kendler (University of British Columbia, Canada) Subsequent Malignant Neoplasms after Hematopoietic Cell Transplantation K Scott Baker (Fred Hutchinson Cancer Research Center, USA)

[LS05] Luncheon Symposium 5: Sanofi-aventis Korea

Date & Time	September 2 (Fri), 12:20-13:00	Room A
Chair	Hee-Je Kim (The Catholic University of Korea, Korea)
Presentation	The Role of ATG in GVHD Prophylaxis: Where do we stand? Dennis Kim (Princess Margaret Cancer Centre, University of Toronto, Canada

[LS06] Luncheon Symposium 6: Bristol Myers Squibb (BMS)

Date & Time	September 2 (Fri), 12:20-13:00	Room B
Chair	Yeung-Chul Mun (Ewha Womans University School of Medicine, Korea)
Presentation	Oral Azacitidine Maintenance Therapy after Intensive Chemotherapy for Transplant-Ineligible AML Patients Andrew Wei (Monash University, Australia)

[LS07] Luncheon Symposium 7: Handok Inc.

Date & Time	September 2 (Fri), 12:20-13:00	Room C
Chair	Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Presentation	Current Perspectives of Hepatic VOD/SOS after Allogeneic Hematopoietic Cell Transplantation; Recent Defitelio Data and Introducing Korean Data Jae-Ho Yoon (The Catholic University of Korea, Korea)

[LS08] Luncheon Symposium 8: MSD KOREA

Date & Time	September 2 (Fri), 12:20-13:00	Room D
Chair	Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
Presentation	Paradigm Change of CMV Prophylaxis-Letermovir Dong-Yeop Shin (Seoul National University College of Medicine, Korea)

[Presidential Symposium] Presidential Symposium

Date & Time	September 2 (Fri), 14:20-15:20	Room A
Chair	Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea)
Presentation	Current Role and Future Direction of Hematopoietic Cell Transplantation Mary Horowitz (Medical College of Wisconsin, USA)

[SS06] Scientific Session 6: Recent Advances in Cellular Immunotherapy

Date & Time	September 2 (Fri), 15:30-17:00	Room A
Chair	Sung-Soo Yoon (Seoul National University College of Medicine, Korea) Nack-Gyun Chung (The Catholic University of Korea, Korea)
Presentations	Next Generation CAR-T Cell Therapy in Multiple Myeloma Sham Mailankody (Memorial Sloan Kettering Cancer Center, USA) Clinical Application of Innovative Cellular Immunotherapy for Cancer Je-Jung Lee (Chonnam National University Medical School, Korea) Infusion of Donor Memory-like NK Cells and Post-Transplant Relapse Rizwan Romee (Harvard Medical School, USA)

[SS07] Scientific Session 7: New Insights of Microbiome in HSCT

Date & Time	September 2 (Fri), 15:30-17:00	Room B
Chair	Jae Hoon Lee (Gachon University College of Medicine, Korea) Seongsoo Jang (University of Ulsan College of Medicine, Korea)
Presentations	Insights into the Role of Gut Microbiota in HSCT: GVHD and Infection Daniele Zama (University of Bologna, Italy) Manipulation of Microbiome in HSCT Edoardo Muratore (University of Bologna, Italy) The Potential Role of Gut Microbiome in the Immunobiology of CAR-T Cell Therapy Christoph K. Stein-Thoeringer (German Cancer Research Center, Germany)

[ES04] Education Session 4: Allogeneic HSCT in Non-Malignant Diseases

Date & Time	September 2 (Fri), 15:30-17:00	Room C
Chair	Kyung-Ha Ryu (Ewha Womans University College of Medicine, Korea) Ki-Seong Eom (The Catholic University of Korea, Korea)
Presentations	Special Strategies of Allogeneic Transplantation in Primary Immune Deficiencies Sung-Yun Pai (National Cancer Institute, USA) Allogeneic HSCT for Transfusion Dependent β-thalassemia (TDT) in the Era of Gene Therapy Sandeep Soni (Stanford University, USA) Haploidentical Transplant and Other Novel Non-Transplant Modalities in Genetic Diseases Suradej Hongeng (Ramathibodi Hospital, Thailand)

[ES05] Education Session 5: Supportive Care with HSCT

Date & Time	September 2 (Fri), 15:30-17:00	Room D
Chair	Deog-Yeon Jo (Chungnam National University College of Medicine, Korea) Jae-Yong Kwak (Chonbuk National University Medical School, Korea)
Presentations	COVID Recommendations Updates in Transplant Patients Sung-Han Kim (University of Ulsan College of Medicine, Korea) Palliative and Advanced Care Planning: End of Life Issues Areej El-Jawahri (Massachusetts General Hospital, Harvard Medical School, USA) Cognitive Function in Blood/Marrow Transplant Survivors Smita Bhatia (University of Alabama at Birmingham, USA)

September 3 (Sat)

[SS08] Scientific Session 8: Current Status and Perspective of GVHD Management

Date & Time	September 3 (Sat), 09:00-10:30	Room A
Chair	Chang-Ki Min (The Catholic University of Korea, Korea) Hyeoung-Joon Kim (Chonnam National University Medical School, Korea)
Presentations	Risk Stratification of GVHD with Clinical Prediction System and Novel Biomarkers John E. Levine (The Tisch Cancer Institute, Mount Sinai School of Medicine, USA) Updated Strategies of GVHD Prevention Ho Sup Lee (Kosin University College of Medicine, Korea) Biology Based Novel Treatment Approaches of GVHD Tomomi Toubai (Yamagata University, Japan)

[SS09] Scientific Session 9: Challenges in Allogeneic Transplantation for MDS

Date & Time	September 3 (Sat), 09:00-10:30	Room B
Chair	Chul Won Jung (Sungkyunkwan University School of Medicine, Korea) Yoo-Jin Kim (The Catholic University of Korea, Korea)
Presentations	The Transplant Decision, before and after: When and who Should Be Considered and how Should Be Prepared Jae-Sook Ahn (Chonnam National University College of Medicine, Korea) The Dilemma of Optimal Conditioning Strategy in MDS: The Stronger, the Better? Sebastian Giebel (Maria Sklodowska-Curie Cancer Center, Poland) Impact of MDS Genomics on Post-Transplant Relapse  Bhagirathbhai Dholaria (Vanderbilt University Medical Center, USA)

[SS10] Scientific Session 10: Transplantation of Pediatric Leukemia

Date & Time	September 3 (Sat), 09:00-10:30	Room C
Chair	Young-Ho Lee (Hanyang University College of Medicine, Korea) Ho Joon Im (University of Ulsan College of Medicine, Korea)
Presentations	The Role of HSCT with Pediatric ALL Patients in the Immunotherapy Era Mattia Algeri (Bambino Gesù Childrens’ Hospital, Italy) Optimal Conditioning Therapy in Childhood ALL Seungmin Hahn (Yonsei University College of Medicine, Korea) Who Should Be Considered to Receive HSCT in Pediatric CML?   Nobuko Hijiya (Columbia University Medical Center, USA)

[ES06] Education Session 6: Optimal Strategies for HSCT with Elderly Patients

Date & Time	September 3 (Sat), 09:00-10:30	Room D
Chair	Chul Won Choi (Korea University School of Medicine, Korea) Deok Hwan Yang (Chonnam National University Medical School, Korea)
Presentations	Geriatric Assessment to Select Optimal Candidates for HSCT Gi June Min (The Catholic University of Korea, Korea) Appropriate Conditioning Regimens in Elderly Patients for HSCT Joon Ho Moon (Kyungpook National University Hospital, Korea) Donor Sources for Older Transplant Recipients and Graft vs. Host Disease Melhem Solh (Blood and Marrow Transplant Program at Northside Hospital, USA)

[SS11] Scientific Session 11: Understanding of Bone Marrow Niche

Date & Time	September 3 (Sat), 10:40-12:10	Room A
Chair	Byung Soo Kim (Korea University College of Medicine, Korea) Myung Geun Shin (Chonnam National University Medical School, Korea)
Presentations	Illuminating Functional Heterogeneity of the Bone Marrow Microenvironment Anastasia N. Tikhonova (University of Toronto, Canada) Immunologic Changes and T-cell Receptor (TCR) Repertoire in Aplastic Anemia and Related Bone Marrow Failure Diseases Satu Mustjoki (University of Helsinki, Finland) Proteomic Analysis of Acute Myeloid Leukemia-Derived Extracellular Vesicles Kwang Pyo Kim (Department of Applied Chemistry, Kyung Hee University, Korea)

[SS12] Scientific Session 12: Advanced Cell Therapy Using Cord Blood

Date & Time	September 3 (Sat), 10:40-12:10	Room B
Chair	Jong Wook Lee (The Catholic University of Korea, Korea) Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
Presentations	Hematopoietic Stem Cell Transplantation Using Single UM171-Expanded Cord Blood: A Single-Arm, Phase 1-2 Safety and Feasibility Study Sandra Cohen (University of Montreal, Canada) Reduced-Intensity Single-Unit Unrelated Cord Blood Transplant with Optional Immune Boost for Nonmalignant Disorders Paul Szabolcs (University of Pittsburgh School of Medicine, USA) Cell Expansion Using Cord Blood Cells - Generation of NK Cells with Cord Blood Cells Yu-Kyeong Hwang (YUYA bio consulting, Korea)

[JS05] Joint Symposium 5: TSBMT-KSBMT: Allogeneic HSCT for HLH

Date & Time	September 3 (Sat), 10:40-11:40	Room C
Chair	Umit Y. Malkan (Hacettepe University, Türkiye) Kyung-Nam Koh (University of Ulsan College of Medicine, Korea)
Presentations	HSCT for HLH or Other Histiocytic Disorders Sule Unal (Hacettepe University, Türkiye) Recent Progress in Hematopoietic Cell Transplantation for Pediatric Patients with Hemophagocytic Lymphohistiocytosis Jin Kyung Suh (Korea Cancer Center Hospital, Korea)

[NS02] Nursing Session 2: New Therapy of Hematologic Malignancies and Infection (Kor.)

Date & Time	September 3 (Sat), 10:40-12:10	Room D
Chair	Hye youn Lee (Seoul National University College of Medicine, Korea)
Presentations	Updates of Therapeutic Strategies in Hematologic Malignancies Ja Min Byun (Seoul National University College of Medicine, Korea) Updates in Management of Infectious Diseases in Hematology Patients Sung-Yeon Cho (The Catholic University of Korea, Korea)